Stock screenerAll disclosures →
EDGAR →
SLGL
Conviction 100HealthcareScan · Mon, Aug 10, 2026SLGL$84.75-3.69%
ResistanceSupportVol 14Insider buyVol MA14 58.12K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price84.75
Change-3.69%
Gap+2.03%
Rel volume2.24×
Avg volume57.08K
Avg $ vol4.75M
SMA 2082.88
SMA 5077.60
SMA 20065.51
Price vs 50+9.21%
Price vs 200+29.36%
MA stackbullish
50/200 cross—
Supertrendup · 71.51
RSI (14)55
MACD hist0.16
MACD crossbull · 4d
Stoch %K / %D46 / 57
ADX (14)38
+DI / −DI26 / 14
RSI divergence—
MACD divergence—
ATR %+6.77%
ADR %7.31%
52w high97.97
52w low15.25
From 52w high-13.49%
Above 52w low+455.74%
New 52w highNo
SqueezeOn · 2d
Bollinger width17.57%
%B0.63
Donchian pos58.12%
Donchian high93.74
Donchian low72.28
AVWAP (52w high)77.69
vs AVWAP high+9.08%
AVWAP (52w low)63.59
vs AVWAP low+33.28%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d2.24×
Avg vol (14d)58.12K
Avg vol (20d)57.08K
Avg $ vol (20d)4.75M
Market cap—
RS 3m (vs SPY)+20.85%
RS 6m (vs SPY)+21.90%
RS line new highNo
Trend template8/8
Technical rank82.6
1 week+3.37%
1 month+14.60%
3 months+19.60%
6 months+28.84%
1 year+480.08%
YTD+101.07%
P/E—
P/B10.81
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq2.86
Current4.37
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value300.88M
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out2.81M
Employees28
ListedThu, Feb 1, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank82.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance92.07
Support69.97
Days since event—
Candle confirm—
News sentiment—
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 15 – Jul 162 scans
- Breaking out nowJul 171 scan
- Broke outJul 20 – Jul 223 scans
- Retesting breakoutJul 231 scan
Congress activity
Disclosed STOCK Act trades in SLGL
No recent disclosed trades by Congress in SLGL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SLGL · 7 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share · 2026-07-14 | Buy | 920 | $68K | 2026-07-14 | 2026-07-15 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share · 2026-07-13 | Buy | 775 | $57K | 2026-07-13 | 2026-07-15 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share · 2026-07-10 | Buy | 229 | $17K | 2026-07-10 | 2026-07-10 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share · 2026-07-08 | Buy | 300 | $22K | 2026-07-08 | 2026-07-10 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share. · 2026-05-20 | Other | — | — | 2026-05-20 | 2026-05-22 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share. · 2026-05-20 | Buy | 1.56K | $101K | 2026-05-20 | 2026-05-22 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share. · 2026-05-13 | Buy | 1.94K | $130K | 2026-05-13 | 2026-05-14 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share. · 2026-05-12 | Other | — | — | 2026-05-12 | 2026-05-14 |
Opaleye Management Inc. 10% owner · Ordinary Shares, par value NIS 1.00 per share. · 2026-05-12 | Buy | 1.5K | $102K | 2026-05-12 | 2026-05-14 |
SEC filings
EDGAR filings in SLGL · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.